4 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
| Phase 2 | 1 | Unknown 1 |
Follow Systemic Vasculitis: new trials by email Literature Review of Systemic Vasculitis trials Research Report on Systemic Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease | Phase 2 / Phase 3 | Unknown | Paul R Fortin | 287 | 2022-03-09 | 2023-01-17 |
| Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis Rituximab, endoxan, Methylprednisolone - ANCA Associated Vasculitis | Phase 3 | Unknown | Leiden University Medical Center | 100 | 2019-05-03 | 2023-12-14 |
| The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach 5 mg prednisone, 0 mg prednisone - Granulomatosis With Polyangiitis, Wegener Granulomatosis | Phase 3 | Unknown | University of South Florida | 12 | 2014-02-17 | 2024-07-29 |
| WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides Azathioprine: 2 mg/kg/day, methotrexate 0.3 mg/kg/week, to a maximum and optimal dose of 25 mg/week - Systemic Wegener's Granulomatosis | Phase 3 | Unknown | Hospices Civils de Lyon | 126 | 1999-01-01 | 2007-10-10 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3) · Granulomatosis with Polyangiitis (2) · Arthritis, Rheumatoid (1) · Cardiovascular Diseases (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Lupus Erythematosus, Systemic (1) · MASS syndrome (1) · Microscopic Polyangiitis (1) · Renal Insufficiency (1) · Respiratory Tract Diseases (1) · Scleroderma, Diffuse (1) · Scleroderma, Systemic (1) · Undifferentiated Connective Tissue Diseases (1)
Autoimmune Diseases (4) · Immune System Diseases (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Cardiovascular Diseases (3) · Skin Diseases, Vascular (3) · Vascular Diseases (3) · Vasculitis (3) · Arthritis (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebral Small Vessel Diseases (1) · Cerebrovascular Disorders (1) · Connective Tissue Diseases (1)
Adrenal Cortex Hormones (1) · Azathioprine (1) · COVID-19 Vaccines (1) · Cyclophosphamide (1) · Glucocorticoids (1) · Methotrexate (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Prednisolone (1) · Prednisone (1) · Rituximab (1)
Hospices Civils de Lyon (1) · Leiden University Medical Center (1) · Paul R Fortin (1) · University of South Florida (1)
Canada (1) · France (1) · Netherlands (1) · United States (1)
Jeffrey P Krischer, PhD (1) · Paul R Fortin, MD,MPH,FRCPC (1) · Peter A Merkel, MD, MPH (1)
PMID 19109574, PMID 28246067, PMID 36130755, PMID 39425055
R01HL115041 (1)